Cover Page
Cover Page - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 25, 2022 | Jun. 30, 2021 | |
Document Information [Line Items] | |||
Document Type | 10-K/A | ||
Amendment Flag | true | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | WVE | ||
Entity Registrant Name | WAVE LIFE SCIENCES LTD. | ||
Entity Central Index Key | 0001631574 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Tax Identification Number | 00-0000000 | ||
Entity Common Stock, Shares Outstanding | 60,859,968 | ||
Entity Public Float | $ 269,680,028 | ||
Title of 12(b) Security | $0 Par Value Ordinary Shares | ||
Security Exchange Name | NASDAQ | ||
Entity File Number | 001-37627 | ||
Entity Incorporation, State or Country Code | U0 | ||
Entity Address, Address Line One | 7 Straits View #12-00 | ||
Entity Address, Address Line Two | Marina One | ||
Entity Address, City or Town | East Tower | ||
Entity Address, Country | SG | ||
Entity Address, Postal Zip Code | 018936 | ||
City Area Code | +65 | ||
Local Phone Number | 6236 3388 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Documents Incorporated by Reference | None. | ||
Amendment Description | This Amendment No. 1 on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K of Wave Life Sciences Ltd. (the “Company,” “we,” “our,” “us” or “Wave”) for the fiscal year ended December 31, 2021, as originally filed with the Securities and Exchange Commission (the “SEC”) on March 3, 2022 (the “Original 10-K”). The purpose of this Amendment is to include information required by Part III of the Annual Report on Form 10-K that was intentionally omitted from Part III of the Original 10-K. In addition, this Amendment amends Item 15 of Part IV of the Original 10-K to update the exhibit list and to include new certifications by our principal executive officer and principal financial officer under Section 302 of the Sarbanes-Oxley Act of 2002, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). | ||
Auditor Name | KPMG LLP | ||
Auditor Firm ID | 185 | ||
Auditor Location | Boston, MA |